Get the Stockscreener App
1.74
2.08%
-0.0369
After Hours:
1.77
0.03
+1.72%
Sellas Life Sciences Group Inc Stock (SLS) Forecast
The Sellas Life Sciences Group Inc (SLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.442, representing a +97.82% increase from the current price of $1.74. The highest analyst price target is $4.1776, and the lowest is $2.7064.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLS Price Target
Average 11.23
(+545.55% Upside)
Is Sellas Life Sciences Group Inc (SLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.52 | Neutral |
| STOCH(9,6) | 58.56 | Neutral |
| STOCHRSI(14) | 93.94 | Sell |
| MACD(12,26) | -0.0294 | Buy |
| ADX(14) | 14.84 | Neutral |
| William %R | -22.20 | Neutral |
| CCI(14) | 177.86 | Buy |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.5547
Buy
|
1.5889
Buy
|
| MA20 |
1.5253
Buy
|
1.5932
Buy
|
| MA50 |
1.738
Buy
|
1.672
Buy
|
| MA100 |
1.7403
Sell
|
1.6937
Buy
|
| MA200 |
1.6144
Buy
|
1.6139
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, SLS could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on SLS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.52 indicates that SLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.56 indicates that SLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 93.94 indicates that SLS is oversold. This suggests that SLS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.84 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 177.86 indicates that SLS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sellas Life Sciences Group Inc financial reports and earnings history, Sellas Life Sciences Group Inc (SLS) stock could reach $1.6208 by 2030, $3.0499 by 2040 and $9.3022 by 2050. See the projected annual prices until 2050 of the Sellas Life Sciences Group Inc stock below:
- Sellas Life Sciences Group Inc (SLS) is expected to reach an average price of $1.9525 in 2035, with a high prediction of $2.0892 and a low estimate of $1.7098. This indicates an $12.21% rise from the last recorded price of $1.74.
- Sellas Life Sciences Group Inc (SLS) stock is projected to chart a bullish course in 2040, with an average price target of $2.7161, representing an $56.10% surge from its current level. The forecast ranges from a conservative $2.6311 to a sky-high $3.0499.
- Our analysts predict Sellas Life Sciences Group Inc (SLS) to jump 112.24% by 2045, soaring from $3.613 to an average price of $3.693, potentially reaching $4.8579. While $3.613 is the low estimate, the potential upside is significant.
- Sellas Life Sciences Group Inc (SLS) stock is expected to climb by 2050, reaching an average of $9.0972, a $422.83% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.3022 and $6.7451, respectively, highlighting the market's uncertainty.
Sellas Life Sciences Group Inc Stock (SLS) Year by Year Forecast
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2026
The predicted value for Sellas Life Sciences Group Inc (SLS) in 2026 is set at an average of $11.23. Estimates vary from a peak of $19.76 to a trough of $2.7064, indicating an +545.55% surge from the present price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.0976 | $2.7064 | $4.1776 | +135.50% |
| February, 2026 | $7.3053 | $3.7189 | $19.76 | +319.85% |
| March, 2026 | $6.391 | $5.8302 | $7.7797 | +267.30% |
| April, 2026 | $9.7431 | $5.783 | $13.53 | +459.95% |
| May, 2026 | $11.00 | $7.404 | $12.56 | +532.46% |
| June, 2026 | $9.4264 | $8.0056 | $11.33 | +441.75% |
| July, 2026 | $8.5385 | $7.3973 | $9.3841 | +390.72% |
| August, 2026 | $11.82 | $8.5689 | $13.74 | +579.32% |
| September, 2026 | $9.8323 | $8.5523 | $15.47 | +465.07% |
| October, 2026 | $9.764 | $8.3431 | $9.954 | +461.15% |
| November, 2026 | $9.6856 | $8.5448 | $11.21 | +456.65% |
| December, 2026 | $9.5777 | $9.1477 | $11.04 | +450.44% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sellas Life Sciences Group Inc (SLS) is $6.3467, with a high forecast of $10.18 and a low forecast of $2.5132. This indicates an +264.75% increase from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.0794 | $8.6986 | $9.6481 | +421.80% |
| February, 2027 | $7.4111 | $7.1762 | $10.18 | +325.92% |
| March, 2027 | $6.7932 | $6.2527 | $7.6419 | +290.41% |
| April, 2027 | $5.9348 | $5.604 | $6.8636 | +241.08% |
| May, 2027 | $5.8165 | $4.6557 | $6.5357 | +234.28% |
| June, 2027 | $6.4986 | $5.7578 | $7.0173 | +273.48% |
| July, 2027 | $7.0903 | $5.109 | $7.8099 | +307.49% |
| August, 2027 | $3.4319 | $3.3519 | $4.6607 | +97.24% |
| September, 2027 | $3.374 | $2.5132 | $4.1136 | +93.91% |
| October, 2027 | $2.7057 | $2.5657 | $3.5453 | +55.50% |
| November, 2027 | $3.0374 | $2.5165 | $3.1473 | +74.56% |
| December, 2027 | $3.5195 | $2.7686 | $3.8594 | +102.27% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2028
In 2028, Sellas Life Sciences Group Inc (SLS) is projected to reach an average price of $3.8056, with a high projection of $6.0058 and a low estimate of $1.6054. This indicates an +118.71% rise from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4011 | $3.3411 | $3.9003 | +95.47% |
| February, 2028 | $2.4428 | $2.4228 | $3.592 | +40.39% |
| March, 2028 | $5.1049 | $2.1937 | $5.3249 | +193.39% |
| April, 2028 | $2.8066 | $2.5412 | $6.0058 | +61.30% |
| May, 2028 | $2.6987 | $2.4287 | $3.1074 | +55.10% |
| June, 2028 | $3.7004 | $2.5291 | $3.9504 | +112.66% |
| July, 2028 | $3.692 | $3.5312 | $4.562 | +112.19% |
| August, 2028 | $1.8041 | $1.7441 | $4.4129 | +3.68% |
| September, 2028 | $1.9858 | $1.6054 | $2.1758 | +14.13% |
| October, 2028 | $2.1175 | $1.757 | $2.1766 | +21.69% |
| November, 2028 | $2.1496 | $1.8779 | $2.2679 | +23.54% |
| December, 2028 | $2.0112 | $1.9908 | $2.2208 | +15.59% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2029
The 2029 price forecast for Sellas Life Sciences Group Inc Stock (SLS) is $1.6551 on average, with a high prediction of $2.3561 and a low estimate of $0.954. This represents an -4.88% decrease from the previous price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.0833 | $1.9629 | $2.3561 | +19.73% |
| February, 2029 | $1.935 | $1.8446 | $2.1089 | +11.21% |
| March, 2029 | $2.0567 | $1.8362 | $2.0867 | +18.20% |
| April, 2029 | $1.7483 | $1.4783 | $2.3475 | +0.48% |
| May, 2029 | $1.3582 | $1.2593 | $1.7488 | -21.94% |
| June, 2029 | $1.5321 | $1.3108 | $1.7617 | -11.95% |
| July, 2029 | $1.5138 | $1.4134 | $1.7534 | -13.00% |
| August, 2029 | $1.0959 | $0.954 | $1.6242 | -37.02% |
| September, 2029 | $1.3937 | $1.0158 | $1.4565 | -19.90% |
| October, 2029 | $1.5296 | $1.378 | $2.1792 | -12.09% |
| November, 2029 | $2.0013 | $1.4201 | $2.0313 | +15.02% |
| December, 2029 | $1.62 | $1.581 | $2.1817 | -6.90% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2030
Sellas Life Sciences Group Inc Stock (SLS) is expected to reach an average price of $4.1888 in 2030, with a high forecast of $7.5868 and a low forecast of $0.7909. This signifies an +140.74% surge from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8382 | $0.8143 | $1.6208 | -51.83% |
| February, 2030 | $0.8275 | $0.7909 | $0.97 | -52.44% |
| March, 2030 | $0.8628 | $0.8094 | $0.926 | -50.42% |
| April, 2030 | $0.8338 | $0.8218 | $0.8904 | -52.08% |
| May, 2030 | $0.8191 | $0.8176 | $0.8459 | -52.93% |
| June, 2030 | $0.8353 | $0.8104 | $0.8463 | -52.00% |
| July, 2030 | $4.6159 | $0.8256 | $7.5868 | +165.28% |
| August, 2030 | $4.4493 | $4.3393 | $5.5976 | +155.71% |
| September, 2030 | $4.3418 | $4.2126 | $5.4501 | +149.53% |
| October, 2030 | $3.5718 | $3.4151 | $4.3235 | +105.28% |
| November, 2030 | $2.6002 | $2.4902 | $4.4243 | +49.43% |
| December, 2030 | $2.2635 | $2.1785 | $2.711 | +30.09% |
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):